可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] INCALZA M A,D’ORIA R,NATALICCHIO A,et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases[J]. Vascul Pharmacol,2018,100(1):1-19.
[2] 任得志,刘勤社,李静,等. 活血胶囊对兔动脉粥样硬化斑块血管内皮细胞生长因子和血管细胞黏附分子-1表达的影响[J]. 中国实验方剂学杂志,2014,20(21):167-170.
[3] 周洁,刘勤社,张晓艳,等. 活血胶囊对家兔动脉粥样硬化斑块稳定性的影响[J]. 中药新药与临床药理,2011,22(5):528-531.
[4] LIU Q S,WANG H F,SUN A K,et al. A comparative study on inhibition of total astragalus saponins and astragaloside IV on TNFR1-mediated signaling pathways in arterial endothelial cells[J]. PLoS One,2014,9(7):e101504.
[5] 王海芳,张琳萍,霍雪萍,等. 黄芪皂苷III抑制小鼠动脉平滑肌细胞TNFR1介导信号转导[J]. 云南中医学院学报,2017,40 (3):1-6.
[6] WANG H,LIU J L,YANG Y,et al. Hydroxy-safflor yellow A inhibits TNFR1-mediated classical NF-κB pathway through inducing shedding of TNFR1[J]. Phytothe Res,2016,30(5):790-796.
[7] WANG H,MA S,LI J,et al. ADAM17 participates in the protective effect of paeoniflorin on mouse brain microvascular endothelial cells[J]. J Cell Physiol,2018,233(12):9320-9329.
[8] QIAO Y,FAN C L,TANG M K. Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury[J]. Drug Des Devel Ther,2017,11:3567-3577.
[9] PEI J P,FAN L H,NAN K,et al. HSYA alleviates secondary neuronal death through attenuating oxidative stress,inflammatory response,and neural apoptosis in SD rat spinal cord compression injury[J]. J Neuroinflammation, 2017,14(1):97.
[10] LI P,LI Z. Neuroprotective effect of paeoniflorin on H2O2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response[J]. Exp Ther Med,2015,9(5):1768-1772.
[11] MOTTERLINI R,FORESTI R. Heme oxygenase-1 as a target for drug discovery[J]. Antioxid Redox Signal,2014,20(11):1810-1826.
[12] SUN J,WEI X,LU Y,et al. Glutaredoxin 1 (GRX1)inhibits oxidative stress and apoptosis of chondrocytes by regulating CREB/HO-1 in osteoarthritis[J]. Mol Immunol, 2017,90:211-218.
[13] GIUDICE A,MONTELLA M. Activation of the Nrf2-ARE signaling pathway:a promising strategy in cancer prevention[J]. Bioessays,2006,28(2):169-181.
[14] SALERNO L,ROMEO G,MODICA M N,et al. Heme oxygenase-1:A new druggable target in the management of chronic and acute myeloid leukemia[J]. Eur J Med Chem,2017,142:163-178.
[15] CHENG Y,RONG J. Therapeutic potential of heme oxygenase-1/carbon monoxide system against ischemia-reperfusion injury[J]. Curr Pharm Des,2017,23(26):3884-3898.
[16] WU N,LI R Q,LI L. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway[J]. Biochem Biophys Res Commun,2018,501(2):343-350.
[17] SCHMOLL D,ENGEL C K,GLOMBIK H. The Keap1-Nrf2 protein-protein interaction:A suitable target for small molecules[J]. Drug Discov Today Technol,2017, 24:11-17.
[18] GIUDICE A,ARRA C,TURCO M C. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents[J]. Methods Mol Biol,2010,647:37-74.
[19] ZHU H,JIA Z,MISRA B R,et al. Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress[J]. Cardiovascular Toxicology,2008,8(2):71-85.
[20] OOI B K,GOH B H,YAP W H. Oxidative stress in cardiovascular diseases:Involvement of Nrf2 antioxidant redox signaling in macrophage foam cells formation[J]. Int J Mol Sci,2017,18(11):E2336.
[21] PALL M L,LEVINE S. Nrf2,a master regulator of detoxification and also antioxidant,antiinflammatory and other cytoprotective mechanisms,is raised by health promoting factors[J]. Acta Physiologica Sinica,2015,67(1): 1-18.